Cargando…
Genome-scale integrated analysis to identify prospective molecular mechanisms and therapeutic targets in isocitrate dehydrogenase 2 R140Q-mutated acute myeloid leukemia
The aim of the present study was to identify potential molecular mechanisms and therapeutic targets in regards to isocitrate dehydrogenase 2 (IDH2) R140Q-mutated acute myeloid leukemia (AML). An RNA sequencing dataset of IDH2 wild-type and R140Q-mutated adult de novo AML bone marrow samples was obta...
Autores principales: | Huang, Rui, Liao, Xiwen, Li, Jing, Wei, Jiemin, Su, Xiayun, Lai, Xiaoxuan, Liu, Beicai, Zhu, Fangxiao, Huang, Yumei, Li, Qiaochuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448125/ https://www.ncbi.nlm.nih.gov/pubmed/30896832 http://dx.doi.org/10.3892/or.2019.7075 |
Ejemplares similares
-
Isocitrate dehydrogenase inhibitors in acute myeloid leukemia
por: Liu, Xiaoyan, et al.
Publicado: (2019) -
Identification and validation of potential prognostic gene biomarkers for predicting survival in patients with acute myeloid leukemia
por: Huang, Rui, et al.
Publicado: (2017) -
Identification of Key Genes and Pathways Associated with RUNX1 Mutations in Acute Myeloid Leukemia Using Bioinformatics Analysis
por: Zhu, Fangxiao, et al.
Publicado: (2018) -
Identification of key pathways and genes in TP53 mutation acute myeloid leukemia: evidence from bioinformatics analysis
por: Huang, Rui, et al.
Publicado: (2017) -
Isocitrate Dehydrogenase Mutations in Myelodysplastic Syndromes and in Acute Myeloid Leukemias
por: Testa, Ugo, et al.
Publicado: (2020)